Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

<p>Abstract</p> <p>Background</p> <p>Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of interm...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ju Andrew W, Wang Hongkun, Oermann Eric K, Sherer Benjamin A, Uhm Sunghae, Chen Viola J, Pendharkar Arjun V, Hanscom Heather N, Kim Joy S, Lei Siyuan, Suy Simeng, Lynch John H, Dritschilo Anatoly, Collins Sean P
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2013-01-01
Edice:Radiation Oncology
Témata:
Stereotactic body radiotherapy
Prostate cancer
SBRT
CyberKnife
Intermediate-risk
Monotherapy
Hypofractionation
On-line přístup:http://www.ro-journal.com/content/8/1/30
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky